Global Specimen Solutions, Inc. provides data management software solutions. It offers translational medicine strategy, informed consent and regulatory, GlobalCODE and snapTRACK. The company was founded by Amelia Wall Warner in 2013 and is headquartered in Raleigh, NC.

Shanghai Meisi Pharmaceutical Technology Co., Ltd. provides clinical research and academic translation services. Its services also include medical education, late phase studies, electronic marketing, evaluation, medical manuscript writing, and editing services. The company was founded by FaBao Zhang and Chun Yang in 2008 and is headquartered in Shanghai, China.

Explain My Surgery, LLC operates as a resource guide on surgical procedures. It offers information on various surgical procedures, and their associated risks and benefits in the categories of abdomen, back, chest, default, extremities, head, neck, and pelvis. The company serves patients and physicians. Explain My Surgery, LLC is based in Las Vegas, Nevada. As of October 2010, Explain My Surgery, LLC operates as a subsidiary of Virtual Medical International, Inc.

FINDEX, Inc. engages in the provision of medical management systems. It operates through the Systems Development and Health Tech segments. The Systems Development segment develops software that specializes in diagnostic imaging filing systems and electronic medical record systems in healthcare. The Health Tech segment deals with medical institution management consulting and medical data analysis. The company was founded on January 26, 1985 and is headquartered in Matsuyama, Japan.

Part of The Est��e Lauder Companies, Inc., ELC Management LLC is an American company that provides management services.

BioInvent is a research-based pharmaceutical company developing innovative antibody drugs targeting cancers with unmet clinical need.Our drug development programmes are supported by our human antibody development platform. This consists of a proprietary antibody library, n-CoDeR:registered:, and in-house technology for the rapid selection, screening and identification of antibodies with excellent affinity and selectivity for targets. BioInvent has a high level of competence in antibody drug discovery, preclinical and clinical development. The Company also has many years' experience in process development and antibody manufacturing, which we carry out at our own facilities. Alongside our in house and partnered drug-development programmes we offer antibody discovery and development services to customers. BioInvent's business model and technology platform have been validated through numerous partnerships. These include a co-development agreement with Bayer, Daiichi Sankyo, Mitsubishi Tanabe, Servier and others. BioInvent employs around 50 people and is based in Lund, Sweden. The Company listed on the NASDAQ OMX Stockholm in 2001.

TheraTech, Inc. manufactures and distributes medical devices. The company was founded by Chick Sanford & Dinesh C. Patel in January, 1985 and is located in Hopkins, MN

Shenzhen AnyCheck Health Information Technology Co., Ltd., established on 2012-11-23, Business scope includes general business items:network technology,medical software,Technology development of health software,technology transfer,technical consulting,Technical Services,system integration;R&D and sales of Class I medical devices;Health and wellness management consulting(Does not contain specific medical behavior);pension investment project,Medical Investment Project(Specific projects shall be submitted for approval separately);Operating import and export business(law,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating);Domestic Trade(Does not contain franchise,Exclusive control,Monopoly).(All of the above are related to the law,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating),The licensing program is:R&D and sales of Class II medical devices,R&D and sales of three types of medical devices.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Oncoceutics, Inc. is a drug discovery and development company targeting the most potent suppressor pathways in human cancer. The company’s leadership team represents a group of drug development executives with unparalleled success in the industry. Central to Oncoceutics’ scientific and technology base is a focus on drug discovery that engages natural potent tumor suppressor pathways. The first lead compound that came out of this program is ONC201, a small molecule that possesses significant anti-tumor activity in a number of different types of human cancer through a unique mechanism of action. The compelling preclinical efficacy and safety of ONC201 along with its favorable chemical properties offer a high potential for safe and meaningful therapeutic benefit to cancer patients in numerous clinical settings. Clinical lead indications for ONC201 are being evaluated in a series of clinical trials that are in various stages of initiation at leading cancer centers around the world. Central to Oncoceutics’ scientific and technology base is a focus on drug discovery that engages natural potent tumor suppressor pathways. The first lead compound that came out of this program is ONC201, a small molecule that possesses significant anti tumor activity in a number of different types of human cancer through a unique mechanism of action. ONC201 induces a striking cytotoxic response within tumors by engaging highly conserved apoptotic response mechanisms. ONC201s unique ability to engage these mechanisms selectively in tumors while sparing normal cells provides a wide spectrum of activity in early and late stage cancers that is accompanied by an attractive safety profile. The compelling preclinical efficacy and safety of ONC201 along with its favorable chemical properties offer a high potential for safe and meaningful therapeutic benefit to cancer patients in numerous clinical settings.

Sanofi is a global healthcare company. Among their duties are researching disease causes, determining starting points for drug treatment, developing drugs, producing active ingredients, and delivering finished drugs and active ingredients. Specialists in vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare.

DelSite, Inc. research-based, biopharmaceutical and consumer products company with a core technology based on naturally occurring complex carbohydrates.\nDelSite is developing its proprietary GelSite technology designed to provide controlled release of peptide and protein-based drugs. More than 130 patents protect its technology.\nIt was incorporated in Texas in 1973, as Carrington Laboratories, Inc.

Manufactures vaccines for diseases like hepatitis, influenza, rubella and typhoid fever

Provid was co-founded in 2001 by Drs. Gary Olson, Christopher Self, and Charles Cook, together with Profs. Amos B. Smith, III and Ralph Hirschmann of the University of Pennsylvania. The team has exceptional talent in synthetic and medicinal chemistry and includes world leaders in peptide and peptide mimetics technology and in structure-based drug design. Their experience makes Provid the premier drug discovery company for early stage research and translational drug development.

Enforme Interactive, Inc. specializes in the creation of websites and web applications. It develops and expands online content, establish new and useful modes of delivery, streamline administrative tasks, and promote events. The frim's products include apprende, an integrated web platform for associations; and secure consent, an electronic informed consent for clinical trials. The company was founded by Carrie Delente and Eric Delente in 1977 and is headquartered in Frederick, MD.

Dalian Yunbang Technology Development Co., Ltd., established on 2003-05-30, Business scope includes licensed projects:Building Intelligent System Design(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion,software development,software sales,Computer System Services,Information system integration service,Retailing of computer software, hardware and auxiliary equipment,Security technology prevention system design and construction services,Security System Monitoring Services,Security equipment sales,Technology Import and Export,Import and export,Sales of Class II Medical Devices(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

They’re Vizuri Health Sciences. A unique healthcare company with a unique goal: We leverage nature-inspired ingredients to help manage the impact of age-related diseases. So adults with a passion for life don’t have to surrender to the years ahead. They can enjoy them. Launched in 2009, they are developing new personal care products, over-the-counter medicines, and prescription medicines by enhancing the benefits of proven, active compounds found in nature through the development of novel technologies and formulations. PainBloc24™, their first product for arthritis joint pain is on the market. And there are more on the way.

NTT DATA Group Corp. engages in the development and integration of information technology (IT) and data communication systems. It operates through the following segments: Public and Social Infrastructure, Financial, Enterprise and Solutions, North America, Europe, Middle East, and Africa (EMEA) and Latin America (LATAM), and Others. The Public and Social Infrastructure segment provides IT services for government, medical, telecommunications, electric power, and other social infrastructures. The Financial segment offers IT services for Japanese financial institutions. The Enterprise and Solutions segment handles IT services that support business activities in the manufacturing, distribution, and services industries. The North America segment offers IT services centering on North America. The EMEA segment provides IT services centering on North America, Europe, Middle East, Africa, and Latin America. The Others segment manages businesses in China and Asia Pacific region. The company was founded on May 23, 1988 and is headquartered in Tokyo, Japan.

Sichuan Passenger Pigeon Technology Co., Ltd., established on 2015-07-14, Business scope includes general items:software development;software sales;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Information system integration service;Network Equipment Sales;Cloud Computing Equipment Technical Services;Wholesale of computer software, hardware and auxiliary equipment;Communication equipment sales;Communication equipment repair;graphic design;Business Management Consulting;Educational Consulting Services(Education and training activities that do not include licensing approval);Advertising Design,acting;Organize cultural and artistic exchange activities;marketing planning;market survey(Does not include foreign investigations);Conference and Exhibition Services;Sales of Class I Medical Devices;Sales of Class II Medical Devices.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Class III medical device business;Construction engineering design;Building Intelligent System Design.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Wuxi Langjia Tongchuang Software Co., Ltd., established on 2017-03-09, Business scope includes research and development and sales of computer software and hardware;computer software,the hardware,System Integration Technology Development,technical consulting,Technical Services,technology transfer;computer consumables,Laboratory equipment and consumables,electronic product,Instrumentation,communication device(Except ground receiving facilities for satellite television broadcasting)promotion of.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Beijing Jiahe Haisen Health Technology Co., Ltd., established on 2019-04-18, Business scope includes technology development,Technology Promotion,technology transfer,technical consulting,Technical Services;data processing(Bank Card Center in Data Processing,PUEvalue in1.4Except for the above cloud computing data centers);product design;model design;Computer System Services;Basic software service;Application software service;Sell ​​self-developed products,computer,Software and Auxiliary Equipment,electronic product,medical instrumentsIIkind;production of medical devicesII,IIIkind(Engage in production activities only in Waifu);Business Management Consulting;Economic and Trade Consulting;health management,Health Advisory(Except for medical treatment activities subject to approval);market survey;Construction Project Management;Preventive Medicine and Hygiene Research Services;Nutrition and Health Consulting,Health Data Analysis;Trade Brokers & Agents;Conference Services,Undertake exhibition and display activities;operating telecommunications business;Internet information service;Sales of Class III Medical Devices.(Market entities independently choose business projects in accordance with the law,Carry out business activities;operating telecommunications business,Internet information service,Sales of Class III medical devices and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)